SMTI
Sanara MedTech Inc.
$23.82
-0.06 (-0.25%)
At close · Jul 10
Market Cap
$218.29M
Shares
9,163,969
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$23.82
Open$24.06
Day$23.28–24.75
52W$16.05–35.95
Avg vol 30d61K
Short int362K · 3.9% float · 4.6d
Short vol47%
Last earningsMay 11, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 12
Up next
Next earnings call
Aug 10, 2026
Est · unconfirmed
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 12, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+5%
above
Price vs 50-day avg
+8%
above
RSI (14)
55
neutral
MACD trend
Positive
52-week position
39%
mid-range
Momentum
relative strength
1-month return
+4%
trailing
6-month return
0%
trailing
YTD return
+2%
this year
Relative strength
−9%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $22 › 200d $23 — 200d above 50d
Institutional flow
Flat
1 of 65 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.95% of float · ▲ +24.6% MoM · 4.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
65 holders — near 3-yr high, broad support
Squeeze score
68
elevated · 0–100
Fundamentals
Revenue growth
+32%
Y/Y
Gross margin
613%
contracting
EPS growth
−282%
Y/Y
Free cash flow
$2.2M
Balance sheet
$29.4M
net debt
Quant / Vol
risk profile
Volatility
63%
annualized · 1-yr
Max drawdown
−54%
past year
ATR
6.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed May 11, 2026
second quarter of 2026
Net revenue
Maintained
$28.5M – $29.5M
prior qtr $27.8M
midpoint +4.3% QoQ
full year ending December 31, 2026
Net revenue
Maintained
$116M – $121M
prior FY $103.12M
midpoint +14.9% Y/Y
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+5%
Bullish
Price vs 50-day avg
+8%
Bullish
RSI (14)
55
Neutral
MACD trend
Positive
Bullish
52-week position
39%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $22 › 200d $23 — 200d above 50d
Institutional flow
Flat
1 of 65 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.95% of float · ▲ +24.6% MoM · 4.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
65 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $16
Now $24 · 39%
52-wk high $36
vs 200-day avg +5%
vs 50-day avg +8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Distributors | 450 | Q1 2026 | — |
| Facilities where products were sold | 1,400 | Q1 2026 | — |
| Hospitals and ambulatory surgery centers contracted or approved | 4,000 | Q1 2026 | — |
| Sales team (reps) | 43 | Q1 2026 | — |
| Adjusted EBITDA non-GAAP | $4.3M | Q1 2026 call | — |
| distributor agreements | 450 | Q1 2026 call | — |
| hospitals and ambulatory surgery centers where products are contracted or approved to be sold | 4,000 | Q1 2026 call | — |
| sales team | 43 | Q1 2026 call | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SMTI
this stock
Sanara MedTech Inc.
|
$218.29M | +2.0% | +32.5% | — | 3.9% |
|
ISRG
Intuitive Surgical Inc
|
$144.30B | -28.2% | +20.5% | 49.5 | 2.1% |
|
MDLN
Medline Inc.
|
$53.91B | -2.3% | +11.5% | — | 2.8% |
|
BDX
Becton Dickinson & Co
|
$41.87B | +0.9% | +8.2% | 57.7 | 4.1% |
|
ALC
Alcon Inc
|
$33.07B | -14.8% | +10.5% | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SMTI | -4.1% | +3.6% | +0.2% | +1.0% | +2.0% |
| SPY | +1.4% | +4.1% | +9.1% | +1.1% | +10.7% |
| vs SPY | -5.5% | -0.5% | -8.9% | -0.1% | -8.7% |